|1 Table of Contents 3
|1.1 List of Tables 5
|1.2 List of Figures 5
2 Introduction 6
2.1 What Is This Report About? 6
2.2 Mammography Equipment Market Segmentation 6
2.3 Definitions of Markets Covered in the Report 7
3 Mammography Equipment Market, United States 8
3.1 Mammography Equipment Market, United States, Revenue ($m), 2018-2033 8
3.1.1 Full Field Digital Mammography Equipment Market, United States, Revenue ($m), by Segment, 2018-2033 10
3.2 Mammography Equipment Market, United States, Volume (Units), 2018-2033 12
3.2.1 Full Field Digital Mammography Equipment Market, United States, Volume (Units), by Segment, 2018-2033 14
3.3 Mammography Equipment Market, United States, Average Price ($), 2018-2033 16
3.4 Mammography Equipment Market, United States, Company Share by Revenue ($m), 2024 17
4 Overview of Key Companies in United States, Mammography Equipment Market 18
4.1 Hologic Inc 18
4.1.1 Company Overview 18
4.2 Siemens Healthineers AG 18
4.2.1 Company Overview 18
4.3 GE HealthCare Technologies Inc 18
4.3.1 Company Overview 18
4.4 Fujifilm Holdings Corp 19
4.4.1 Company Overview 19
5 Mammography Equipment Market Pipeline Products 20
6 Financial Deals Landscape 21
6.1 Debt Offerings 21
6.1.1 GE HealthCare Technologies Raises USD1 Billion in Public Offering of
4.800% Senior Notes Due 2029 21
6.2 Equity Offerings 23
6.2.1 GE HealthCare Technologies to Raise Funds in Secondary Offering of Shares 23
6.2.2 GE HealthCare Technologies Prices to Raise USD1.29 Billion in Upsized Secondary Offering of Shares 24
7 Recent Developments 25
7.1 Corporate Communications 25
7.1.1 Dec 09, 2024: Hologic Appoints Dr. Martin Madaus to Its Board 25
7.1.2 Sep 11, 2024: Solis Mammography Earns Great Place to Work Certification for Third Year in a Row 25
7.2 Financial Announcements 25
7.2.1 Jul 02, 2025: Hologic to Announce Financial Results for the Third Quarter of Fiscal 2025 on Wednesday, July 30, 2025 25
7.2.2 Apr 17, 2025: GE HealthCare to Announce First Quarter 2025 Results on April 30, 2025 26
7.2.3 Apr 03, 2025: Revvity to Hold Earnings Call on Monday, April 28, 2025 26
7.2.4 Mar 19, 2025: iCAD Posts Results for Q4 and Fiscal Year Ended December 31, 2024 26
7.2.5 Feb 05, 2025: Hologic Reports Results for Q1 of Fiscal 2025 27
7.2.6 Jan 31, 2025: Revvity Announces Financial Results for the Fourth Quarter and Full Year of 2024 28
7.2.7 Jan 12, 2025: Revvity to Hold Earnings Call on Friday, January 31, 2025; Provides Update on Financial Performance 29
7.2.8 Jan 06, 2025: Hologic to Announce Financial Results for the First Quarter of Fiscal 2025 on Wednesday, February 5, 2025 29
7.2.9 Dec 12, 2024: GE HealthCare to Announce Fourth Quarter and Full Year 2024 Results on February 13, 2025 29
7.2.10 Nov 12, 2024: Oxford Instruments Announces Half-Year Results 29
7.2.11 Nov 04, 2024: Revvity Announces Financial Results for the Third Quarter of 2024 30
7.2.12 Oct 07, 2024: Revvity to Hold Earnings Call on Monday, November 4, 2024 31
7.2.13 Oct 04, 2024: Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2024 on Monday, November 4, 2024 31
7.3 Government and Public Interest 32
7.3.1 Jul 10, 2025: Study: Quick, Pain-Free Breast Imaging System Shows Promise in Early Clinical Tests 32
7.3.2 Mar 27, 2025: Vanqua Bio to Present at the AD/PD 2025 International Conference 33
7.3.3 Mar 17, 2025: Enveric Biosciences Participating in BIO-Europe Spring 33
7.3.4 Feb 10, 2025: GE Healthcare Management to Present at Upcoming Investor Conference 34
7.3.5 Nov 19, 2024: Revvity to Present at 7th Annual Evercore ISI HealthCONx Conference 34
7.3.6 Oct 09, 2024: Livzon Pharmaceutical Group Announcement on the Approval for the New Indication of Triptorelin Acetate Microspheres for Injection 34
7.3.7 Oct 03, 2024: Aldeyra Therapeutics Resubmits Reproxalap New Drug Application for the Treatment of Dry Eye Disease 36
7.3.8 Aug 12, 2024: FDA approves IASO Bio’s IND for equecabtagene autoleucel 36
7.4 Legal And Regulatory 37
7.4.1 Jan 08, 2025: Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE (amifampridine) Patent Litigation with Teva Pharmaceuticals 37
7.5 Other Significant Developments 38
7.5.1 Oct 07, 2024: WakeMed and Siemens Healthineers Bring Vital Mammography Screenings to the Community During Breast Cancer Awareness Month 38
7.5.2 Oct 01, 2024: Am I Too Young for a Mammogram 38
7.5.3 Sep 10, 2024: New Breast Density Reporting Requirement Empowers Women with Vital Information; Susan G. Komen(R) Urges Access to Affordable Care 39
7.6 Product News 40
7.6.1 Jul 15, 2025: RSNA: AI Tool Accurately Detects Tumor Location on Breast MRI 40
7.6.2 Feb 26, 2025: DeepHealth Introduces New AI-Powered Radiology Informatics and Population Screening Solutions at ECR2025 41
7.6.3 Oct 08, 2024: Tra Medical Imaging Foundation Brings Mobilemammo NW to the South Sound 42
7.6.4 Oct 01, 2024: Mayo Clinic Health System Discusses Advancements in Breast Cancer Screenings 42
7.6.5 Sep 17, 2024: Advanced 3D Mammography Detects More Breast Cancers, Fewer False Positives 43
7.6.6 Aug 16, 2024: Safe Seated Mammography Using Enable Me's VELA Mammography Chair Can Improve Image Clarity this World Breast Cancer Research Day Aug. 18 43
7.7 Strategy And Business Planning 44
7.7.1 Jul 10, 2025: Shionogi Announces Implementation of Stibo Systems MDM Solution 44
7.7.2 May 12, 2025: Fujifilm Strengthens Partnership With the National Rural Health Association To Improve Access to Medical Imaging in Rural Communities 44
7.7.3 Oct 10, 2024: US Radiology Specialists Launches Next Phase of its Technologist Advancement Academy With Expansion Into Mammography 45
8 Appendix 46
8.1 Research Methodology 47
8.1.1 Coverage 47
8.1.2 Secondary Research 47
8.1.3 Primary Research 47
8.1.4 Market Modeling and Forecasting 48
8.1.5 Company Share Analysis 49
8.1.6 Benchmarking 50
8.2 GlobalData Consulting 50
8.3 Contact Us 50
8.4 Disclaimer 51